💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…
Profile for MannKind Corporation (MNKD)
« Back to company indexMNKD Chatter Timeline
Stock Ticker for MNKD
Most Active Tweeters for MNKD
| User | Tweets |
|---|---|
| @Tickeron | 18 |
| @PennySearch | 5 |
| @Vrod_cowboy | 2 |
| @QuantchaIdeas | 2 |
| @invescent | 2 |
Recent Tweets for MNKD
 |
@Jarvis_Alerts $MNKD 4C Exp:18-Mar-22 ? ? Total(Day): $60,000 #UnusualActivity Sign-up free for beta ver.:… https://t.co/64Ow8Lyqy5 January 25th 2022, 10:01pm |
 |
@TripTwit Have been buying $XERS and $MNKD hand over fist during this market swoon. Adding to my core in both. Time will tell if I’m too early. January 25th 2022, 7:01pm |
 |
@Tickeron $MNKD in Downtrend: 50-day Moving Average crossed below 200-day Moving Average on January 13, 2022. View odds for t… https://t.co/A2tiXNp5m9 January 25th 2022, 11:01am |
|
@Tickeron A.I.dvisor made a bearish call on $MNKD, netting in a 16.63% gain over 3 weeks #MannKind https://t.co/lBQNDg7bcT https://t.co/ghGP79qLwN January 25th 2022, 10:01am |
|
@Tickeron A.I.dvisor made a bearish call on $MNKD, netting in a 16.63% gain over 3 weeks #MannKind https://t.co/ewvcAWrm7r https://t.co/p9L5CuFHOS January 25th 2022, 6:01am |
 |
@JSchremp22 RT @catalystinvstor: Tyvasso Dpi approval next month will bring steady revenue stream for $MNKD. Below you can see the current revenue that… January 25th 2022, 3:01am |
 |
@PennySearch $MNKD RBC Capital gave MNKD a Sector Perform stock rating on 2021-05-14. Find top penny stocks with PennySearch… https://t.co/dyZSnHcSBi January 24th 2022, 9:01pm |
|
@PennySearch $MNKD RBC Capital gave MNKD a Sector Perform stock rating on 2021-05-14. Find top penny stocks with PennySearch… https://t.co/gAvn2M3RvW January 24th 2022, 6:01am |
|
@Tickeron $MNKD in Downtrend: 50-day Moving Average broke below 200-day Moving Average on January 13, 2022. View odds for thi… https://t.co/8DLF7PEsSw January 24th 2022, 5:01am |
|
@PennySearch $MNKD RBC Capital gave MNKD a Sector Perform stock rating on 2021-05-14. Find top penny stocks with PennySearch… https://t.co/CGo3zPn79Q January 23rd 2022, 9:01pm |
 |
@Vrod_cowboy $mnkd https://t.co/9YThwfIAU1 January 23rd 2022, 8:01pm |
 |
@invescent $MNKD Data indicates that the overall analyst sentiment for MNKD is bullish. Simplify the way you research stock… https://t.co/VyPfkln9E8 January 22nd 2022, 5:01pm |
|
@Tickeron $MNKD in Downtrend: 50-day Moving Average moved below 200-day Moving Average on January 13, 2022. View odds for thi… https://t.co/abpjeNSV8m January 22nd 2022, 4:01pm |
 |
@Gambiste1 RT @invescent: $MNKD Data indicates that the overall analyst sentiment for MNKD is neutral Simplify the way you research stocks with our… January 22nd 2022, 1:01pm |
|
@invescent $MNKD Data indicates that the overall analyst sentiment for MNKD is neutral Simplify the way you research stocks… https://t.co/tecgljieEe January 22nd 2022, 1:01pm |
|
@PennySearch $MNKD RBC Capital gave MNKD a Sector Perform stock rating on 2021-05-14. Find top penny stocks with PennySearch… https://t.co/baWcnSVfOz January 22nd 2022, 5:01am |
 |
@QuantchaIdeas Covered Call Alert: MANNKIND $MNKD returning up to 30.06% through 20-May-2022 https://t.co/IQqCqgJ0AU January 21st 2022, 4:01pm |
|
@QuantchaIdeas Covered Call Alert: MANNKIND $MNKD returning up to 30.06% through 20-May-2022 https://t.co/5jcss5LYTS January 21st 2022, 4:01pm |
 |
@catalystinvstor Tyvasso Dpi approval next month will bring steady revenue stream for $MNKD. Below you can see the current revenue t… https://t.co/qCw8hmQvP3 January 21st 2022, 3:01pm |
|
@Tickeron $MNKD in Downtrend: 50-day Moving Average crossed below 200-day Moving Average on January 13, 2022. View odds for t… https://t.co/QspHN7Atds January 21st 2022, 9:01am |
 |
@TraderOfStocks1 $MNKD https://t.co/a2v6zt86uh January 21st 2022, 12:01am |
|
@Tickeron $MNKD in Uptrend: price may jump up because it broke its lower Bollinger Band on January 12, 2022. View odds for th… https://t.co/kyIlBmCQOJ January 20th 2022, 6:01pm |
 |
@ChartMill The technical rating of $MNKD is bad and it also does not present a quality setup at the moment.… https://t.co/0LouLJMWwL January 20th 2022, 2:01pm |
|
@Tickeron What do you think of this? $MNKD Stochastic Oscillator left the oversold zone. #MannKind https://t.co/VaJ9VU79Ls https://t.co/kpgsDKRCqV January 20th 2022, 12:01pm |
 |
@LyinChris1 $MNKD ~~Find active market alerts here in this best trading community. https://t.co/bzZTCi2RzY January 20th 2022, 4:01am |
 |
@skelly031212 @LadeBackk $MNKD..? January 20th 2022, 2:01am |
 |
@zerofiltertruth $MNKD on watch going forward for breakthrough above 20 / 50 / 200-day as progress & excitement around #TyvasoDPI gr… https://t.co/4CNL2QoYRv January 19th 2022, 2:01pm |
|
@Tickeron $MNKD in -8.29% Downtrend, sliding for three consecutive days on January 13, 2022. View odds for this and other ind… https://t.co/27OufSvEkm January 19th 2022, 11:01am |
 |
@TradeWithAlerts Nice print for $MNKD Size: 690848 Price: 3.97 Amount: $2,742,666.56 Time: 1600 See more: https://t.co/UeMntboFt0 Jo… https://t.co/d6n0zfuFx5 January 18th 2022, 9:01pm |
 |
@mehabecapital $MNKD @ 4.08 (+3.57%) : MannKind updates on marketing application for Tyvaso DPI https://t.co/JqojkIFFH6 January 18th 2022, 5:01pm |
 |
@MarketCurrents $MNKD $UTHR - MannKind updates on marketing application for Tyvaso DPI https://t.co/szAfPTG7WB January 18th 2022, 5:01pm |
 |
@AlertTrade REVERSALtoUP: $MNKD MannKind Corporation ? TradeIdeas via ? https://t.co/VS8RO0TZ6b January 18th 2022, 3:01pm |
|
@zerofiltertruth $MNKD pulse January 18th 2022, 3:01pm |
 |
@BWcapital_ $UTHR $MNKD United disclosed that the FDA has acknowledged acceptance of the NDA for review as a CLASS 1 response… https://t.co/9qnBR341hQ January 18th 2022, 2:01pm |
|
@Biotechstock2 $MNKD the fda acceptance and Feb 2022 date should be great news for the share price in the short term January 18th 2022, 2:01pm |
|
@Tickeron $MNKD in Uptrend: price expected to rise as it breaks its lower Bollinger Band on January 12, 2022. View odds for t… https://t.co/9SoyOXlKdM January 18th 2022, 1:01pm |
 |
@FlashAlert_me $MNKD [15s. delayed] filed form 8-K on January 18, 07:00:30 https://t.co/CVbSJhif3R January 18th 2022, 12:01pm |
 |
@investor_feed $MNKD 8-K Mannkind (18 Jan, 7:00am) ? Other Events https://t.co/23kkAyAKBI #MNKD #8K #Mannkind #News January 18th 2022, 12:01pm |
 |
@Market_Newswire $MNKD SEC Filing: 8-K Other Events - MANNKIND CORP (0000899460) January 18 https://t.co/ZUqJgR8gb5 January 18th 2022, 12:01pm |
 |
@SilvioDanailov RT @ralm745027: @manpreetkailon $MNKD https://t.co/EVpUTjnck6 January 17th 2022, 8:01pm |
 |
@ralm745027 @manpreetkailon $MNKD https://t.co/EVpUTjnck6 January 17th 2022, 7:01pm |
 |
@MannOntop2 RT @kcphaeton: $MNKD This POS doesn’t have this kind of money but he should never be allowed to be in any business, especially the Pharma b… January 17th 2022, 7:01pm |
 |
@pretiming $MNKD Jan 14 => Sell ? Search for 10 day stock forecast by pretiming… https://t.co/IULjxelRl9 January 17th 2022, 5:01am |
|
@Tickeron $MNKD in Uptrend: price may ascend as a result of having broken its lower Bollinger Band on January 12, 2022. View… https://t.co/szpmne8vgo January 17th 2022, 4:01am |
|
@PennySearch $MNKD RBC Capital gave MNKD a Sector Perform stock rating on 2021-05-14. Find top penny stocks with PennySearch… https://t.co/NedEOWlhhh January 16th 2022, 7:01pm |
|
@Vrod_cowboy @Complex $mnkd @Afrezza_1 New hire to bring shareholder return on investment January 15th 2022, 6:01pm |
|
@Tickeron $MNKD was the market's top winner yesterday, jumping +4.26% #MannKind https://t.co/u6ic1p8klX January 15th 2022, 7:01am |
|
@Tickeron How do you think the market will react to this? $MNKD RSI Indicator left the oversold zone. #MannKind… https://t.co/uYMuFjeEtT January 15th 2022, 7:01am |
 |
@kcphaeton $MNKD This POS doesn’t have this kind of money but he should never be allowed to be in any business, especially the… https://t.co/1StpNhA3bd January 15th 2022, 1:01am |
 |
@sammukhtar $MNKD a fresh old favorite. January 14th 2022, 3:01pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2022. All rights reserved.
DrugPatentWatch Video Training
Decision-making for generic drug entry and branded drug lifecycle management
By tracking patent expirations, patent litigation, generic and biosimilar development, you can anticipate these market-shaping forces and stay one step ahead.
This course answers the following questions to help you adapt:
- ✓ When will key drug patents expire?
- ✓ How can I find, evaluate, and plan for generic market entry opportunities?
- ✓ How can I find proprietary out-of-court settlements and deal terms?